^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AMG 337

    i
    Other names: AMG 337, AMG337, AMG-337
    Associations
    News

    Trials

    Company:
    Amgen, ImmunityBio
    Drug class:
    c-MET inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810)
    Phase 2
    Eastern Cooperative Oncology Group
    Withdrawn
    Last update posted :
    05/25/2023
    Initiation :
    03/06/2015
    Primary completion :
    03/06/2015
    HER-2 • MET
    |
    HER-2 negative • MET amplification • MET expression
    |
    5-fluorouracil • oxaliplatin • leucovorin calcium • AMG 337
    A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects (NCT02096666)
    Phase 1/2
    Amgen
    Completed
    Last update posted :
    12/28/2021
    Initiation :
    04/15/2014
    Primary completion :
    11/05/2015
    Completion :
    12/07/2018
    MET
    |
    MET amplification
    |
    AMG 337
    QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors (NCT03147976)
    Phase 2
    NantPharma, LLC
    Withdrawn
    Last update posted :
    08/28/2019
    Initiation :
    05/02/2018
    Primary completion :
    08/23/2019
    Completion :
    08/23/2019
    MET
    |
    MET exon 14 mutation • MET overexpression • MET mutation
    |
    AMG 337